Abstracts tagged "morbidity and mortality and rheumatoid arthritis (RA)"

Abstract Number: 1351 • 2019 ACR/ARP Annual Meeting
Mortality of Rheumatoid Arthritis Patients, Treated to Target at Low Disease Activity: 17-years Follow-up of the BeSt Cohort
Johanna M Maassen¹, YPM Goekoop ², JHLM van Groenendael ³, WF Lems ⁴, PJSM Kerstens ⁵, Thomas Huizinga ⁶ and CF Allaart ¹, ¹Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, ²Haga Hospital, 's-Gravenhage, Netherlands, ³Reumazorg Zuid West Nederland, Rozendaal, Netherlands, ⁴Amsterdam UMC, Amsterdam, Netherlands, ⁵Westfriesgasthuis, Hoorn, Netherlands, ⁶Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Rheumatoid arthritis is known to be associated with increased mortality over the years when compared to the general population. In the BeSt study, 508…
Abstract Number: 219 • 2018 ACR/ARHP Annual Meeting
Impact of Rheumatoid Arthritis on Influenza-Related Complications: A Population Based Cohort Study
Preethi Gondi Kamma Venkatesh¹ and Xiang Zhu², ¹Internal Medicine, Florida Hospital, Orlando, FL, ²Florida Hospital, Orlando, FL
Background/Purpose: Rheumatoid Arthritis (RA) is associated with increased incidence of seasonal influenza and its complications. Population-based studies on outcomes are lacking. The aim of our…
Abstract Number: 225 • 2018 ACR/ARHP Annual Meeting
U.S. Trends in Hospitalization Rates and Causes and in-Hospital Mortality in Rheumatoid Arthritis Patients, 2000-2014
Namrata Singh¹, Yubo Gao², Elizabeth Field³, Petar Lenert⁴, Jeffrey R. Curtis⁵ and Mary Vaughan-Sarrazin², ¹Internal Medicine, Iowa City VA Medical Center and University of Iowa, Iowa City, IA, ²University of Iowa Hospitals and Clinics, Iowa City, IA, ³Iowa City VA, Iowa City, IA, ⁴333 MRC Dept of Internal Med, University of Iowa, Iowa City, IA, ⁵University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Over the past two decades, major advances have been made in the treatment of RA, allowing disease remission to become an achievable goal. Although…
Abstract Number: 2819 • 2018 ACR/ARHP Annual Meeting
Alcohol Consumption and the Risk of Coronary Heart Disease and Mortality in Patients with Rheumatoid Arthritis
Isaac Smith¹, Jie Wei², Yuqing Zhang³, Hyon K. Choi² and Marcy Bolster¹, ¹Massachusetts General Hospital, Boston, MA, ²Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, ³Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA
Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased risk of premature cardiovascular events and mortality. Prospective general population studies have shown moderate alcohol consumption…
Abstract Number: 11L • 2017 ACR/ARHP Annual Meeting
Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards: A Danish Population-Based Cohort Study
Lene Dreyer¹, René Cordtz², Inger Marie J. Hansen³, Lars Erik Kristensen⁴, Merete Lund Hetland⁵ and Lene Mellemkjær⁶, ¹Center for Rheumatology and Spine Diseases, Gentofte University Hospital,Rigshospitalet, Hellerup, Denmark, ²Center for Rheumatology and Spine Diseases, Gentofte University Hospital, Rigshospitalet, Hellerup, Denmark, ³Department of Reumatology, OUH, Svendborg Hospital, Svendborg, Denmark, ⁴The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen F, Denmark, ⁵DANBIO, Glostrup Hospital.On behalf of all Depts of Rheumatology in Denmark.Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark, Glostrup, Denmark, ⁶Danish Cancer Society Research Center, Copenhagen, Denmark, Copenhagen, Egypt

Background/Purpose: The safety of treatment with biological DMARDs (bDMARDs) has been carefully studied for the past 15 years, however, it is still largely unknown whether…
Abstract Number: 420 • 2017 ACR/ARHP Annual Meeting
Machine Learning in Rheumatology: Development and Validation of a Predictive Model for Rheumatoid Arthritis Mortality Using Random Survival Forests
Luis Rodriguez-Rodriguez¹, José M Lezcano-Valverde², Fernando Salazar³, Leticia León², Esther Toledano⁴, Juan A Jover Jover⁵, Eduardo Soudah³, Benjamín Fernández-Gutiérrez⁵, Isidoro Gonzalez-Alvaro⁶ and Lydia A Alcazar¹, ¹Rheumatology Department and Heath Research Institute (IdISSC), Hospital Clinico San Carlos, Madrid, Spain, ²Rheumatology Department, Hospital Clínical San Carlos, and IdISSC, Madrid, Spain, ³International Centre for Numerical Methods in Engineering (CIMNE), Madrid, Spain, ⁴Rheumatology, Hospital Clínical San Carlos, Madrid, Spain, ⁵Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ⁶Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid, Spain
Background/Purpose: Rheumatoid arthritis (RA) is associated with increased mortality. Traditional survival techniques used to identify mortality risk factors, such as the Cox proportional hazards model…
Abstract Number: 524 • 2017 ACR/ARHP Annual Meeting
Predictors of Mortality in RA Patients before Biologic Therapy
Debora Cordeiro Rosario¹, Camila Nobre Bulhoes¹, Rodrigo Peres Toledo¹, Karina Bonfiglioli², Ana C.M. Ribeiro³, Julio C. B. Moraes², Carla G.S. Saad², Clovis A Silva⁴, Eloisa Bonfa⁵ and Nadia E Aikawa², ¹Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, ²Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ³Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁴Pediatric Rheumatology Unit, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁵Rheumatology Divison, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Background/Purpose: Several studies have evaluated mortality risk factors in rheumatoid arthritis (RA) but that are no data regarding baseline predictors of mortality in patients under…
Abstract Number: 2392 • 2017 ACR/ARHP Annual Meeting
Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Namrata Singh¹, Jimmy Varghese², Bryant R. England³, Joshua J. Solomon⁴, Kaleb Michaud⁵, Ted R. Mikuls⁶ and Marin Schweizer⁷, ¹Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA, ²Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, ³Division of Rheumatology & Immunology, Department of Internal Medicine, Nebraska-Western IA VA Health Care System & University of Nebraska Medical Center, Omaha, NE, ⁴Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO, ⁵University of Nebraska Medical Center, Omaha, NE, ⁶Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, ⁷Internal Medicine, Iowa City VA, Iowa City, IA
ABSTRACT Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A systematic review and meta-analysis Background/Purpose: Interstitial lung disease affects 10-15%…
Abstract Number: 2412 • 2017 ACR/ARHP Annual Meeting
Mortality and Clinical Features in Rheumatoid Arthritis and Interstitial Lung Disease
Cristina Vadillo Font¹, Maria Asunción Nieto², Leticia Leon³, Luis Rodriguez-Rodriguez⁴, Judit Font Urgelles¹, Esperanza Pato Cour¹, Juan Angel Jover⁵ and Lydia A Alcazar⁶, ¹Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ²Pneumology. Hospital Clínico San Carlos, MD PhD, Madrid, Spain, ³Rheumatology, Department of Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, ⁴Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ⁵Rheumatology. Hospital Clínico San Carlos, MD PhD, Madrid, Spain, ⁶Rheumatology Department and Heath Research Institute (IdISSC), Hospital Clinico San Carlos, Madrid, Spain
Background/Purpose: Interstitial lung disease (ILD) is the most common extra-articular manifestation in Rheumatoid Arthritis (RA) generating higher mortality in these patients. The objective is to…
Abstract Number: 2911 • 2017 ACR/ARHP Annual Meeting
Low Appendicular Bone Mass Predicts Mortality in Patients with Rheumatoid Arthritis
Mark Edward Hall¹, Inmaculada del Rincon², Jose Felix Restrepo², Daniel F. Battafarano³, Jakob Algulin⁴ and Agustin Escalante², ¹Internal Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, ²Internal Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, ³Medicine, San Antonio Military Medical Center, San Antonio, TX, ⁴Sectra AB, Linköping, Sweden
Background/Purpose: Rheumatoid Arthritis (RA) is a multi-system disease which causes joint damage and is associated with increased cardiovascular (CV) morbidity and osteoporosis. Our purpose is…
Abstract Number: 1236 • 2016 ACR/ARHP Annual Meeting
Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs
Karina Raimundo¹, Amanda Farr², Ashley Cole³ and Jeffrey J. Swigris⁴, ¹Genentech, Inc., a Member of the Roche Group, South San Francisco, CA, ²Truven Health Analytics, Cambridge, MA, ³Truven Health Analytics, Bethesda, MD, ⁴Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO
Background/Purpose: Interstitial lung disease (ILD) is commonly associated with rheumatoid arthritis (RA) and can have significant morbidity and mortality. The objective was to calculate the…
Abstract Number: 1479 • 2016 ACR/ARHP Annual Meeting
Cardiovascular Diseases and Mortality Are Independently Influenced By Carotid Plaque Presence in Rheumatoid Arthritis: The 5-Year Prospective Study
Jung Su Eun¹, Eun Song Lee², Jong Wan Kang¹, Na Ri Kim¹, Ji Hun Kim¹, Jin Young Kang¹, Eon Jeong Nam³ and Young Mo Kang¹, ¹Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea, The Republic of, ²Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea, The Republic of, ³Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, South Korea
Background/Purpose: Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular disease (CVD) and premature mortality, compared to the general population. Inflammatory burden and conventional…
Abstract Number: 1994 • 2016 ACR/ARHP Annual Meeting
Associations of Chronic Lung Comorbidity with Medications, Disease Activity, and All-Cause Mortality in Rheumatoid Arthritis
Bryant R. England^1,2, Harlan Sayles³, Kaleb Michaud^3,4, Liron Caplan⁵, Lisa A. Davis^6,7, Grant W. Cannon⁸, Brian Sauer⁹, E. Blair Solow¹⁰, Andreas Reimold¹¹, Gail S. Kerr¹², Pascale Schwab¹³, Joshua F. Baker¹⁴, Namrata Singh¹⁵ and Ted R. Mikuls¹⁶, ¹VA Nebraska-Western Iowa, Omaha, NE, ²Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ³University of Nebraska Medical Center, Omaha, NE, ⁴National Data Bank for Rheumatic Diseases, Wichita, KS, ⁵Div of Rheumatology, Denver VAMC and Univ of Colorado School of Medicine, Aurora, CO, ⁶Denver VAMC and Univ of Colorado School of Medicine, Aurora, CO, ⁷Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO, ⁸Internal Medicine, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ⁹IDEAS Center and Division of Epidemiology, HSR&D SLC VA Medical Center and University of Utah, Salt Lake City, UT, ¹⁰Rheumatology, UT Southwestern Medical Center, Dallas, TX, ¹¹Dallas VA Medical Center and University of Texas Southwestern Medical Center, Dallas, TX, ¹²Washington DC VAMC, Georgetown University Hospital, Howard University Hospital, Washington, DC, ¹³Div Arth & Rheum Dis, Portland VA and Oregon Health & Science University, Portland, OR, ¹⁴Medicine/Rheumatology, University of Pennsylvania and Philadelphia VAMC, Philadelphia, PA, ¹⁵Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA, ¹⁶Veteran Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE
Background/Purpose: While the impact of interstitial lung disease (ILD) on mortality in RA has been demonstrated, less is known about the influence of other lung…
Abstract Number: 2652 • 2016 ACR/ARHP Annual Meeting
Rheumatoid Arthritis and Excess Mortality Associated with Treatments: a Systematic Review and Meta-Analysis
Manon Redondin¹, B Combe², Cécile Gaujoux-Viala³, Jacques Morel⁴ and Cédric Lukas⁵, ¹CHU Lapeyronie, University of Montpellier, France, ²Immuno-Rhumatologie, CHU Lapeyronie, University of Montpellier, France, ³CHU Nîmes, University of Montpellier, France, ⁴Rheumatology, Department of Rheumatology, Montpellier University Hospital, Montpellier, France, ⁵Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France
Background/Purpose: Patients with rheumatoid arthritis (RA) have a lower life expectancy than general population. The impact of RA treatments on global mortality is not…
Abstract Number: 3052 • 2016 ACR/ARHP Annual Meeting
Causes of Death for Patients with Rheumatoid Arthritis
Jessica Widdifield¹, Michael Paterson², Anjie Huang³, Bindee Kuriya⁴, Carter Thorne⁵, Janet E. Pope⁶, Claire Bombardier⁷ and Sasha Bernatsky⁸, ¹McGill University, Toronto, ON, Canada, ²Institute of Clinical Evaluative Sciences, Toronto, ON, Canada, ³Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁴Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁵University of Toronto and Southlake Regional Health Centre, Newmarket, ON, Canada, ⁶University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ⁷University of Toronto, Toronto, ON, Canada, ⁸Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: Information on causes of death can assist in monitoring health trends and discovering health gaps. Our aim was to determine the primary causes of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].